Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis
Rungrot Bencharattanaphakhi, MD, Pawinee Rerknimitr, MD, MSc
JAAD Case Reports · 2021
doi:10.1016/j.jdcr.2021.10.002 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
During the COVID-19 pandemic, several vaccine platforms have been generated against this virus, including inactivated whole-virus vaccines, namely CoronaVac (Sinovac Life Sciences).1 It is used particularly in Asia, the Middle East, and South America.2 Dermatologic reactions such as erythema, swelling, and urticaria have been reported.1 Cutaneous vascular inflammation, however, has not been reported from the use of Sinovac (CoronaVac). We, herein, report 2 cases of CoronaVac-induced cutaneous vasculitis.
Abstract licence: CC BY-NC-ND
References6
6 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.